Mostrando 9 resultados de: 9
Publisher
American Journal of Therapeutics(4)
Revista Latinoamericana de Hipertension(3)
Archivos Venezolanos de Farmacologia y Terapeutica(2)
Área temáticas
Enfermedades(7)
Farmacología y terapéutica(5)
Salud y seguridad personal(5)
Fisiología humana(3)
Problemas sociales y servicios a grupos(2)
Área de conocimiento
Enfermedad cardiovascular(5)
Epidemiología(2)
Farmacología(2)
Fisiología(2)
Medicina interna(2)
Origen
scopus(9)
Cigarette smoking and cardiovascular disease
ReviewAbstract: Cigarette smoking is considered a risk factor for many diseases especially for cardiovascular diseasPalabras claves:Cardiovascular disease, risk factor, smokingAutores:Aguirre M.A., Aparicio D., Bustamante M., Canelón R., Finol F., Luis Xavier Enríquez Acosta, Urdaneta A., Valmore Bermúdez, Velasco M.Fuentes:scopusAn elevated level of physical activity is associated with normal lipoprotein(a) levels in individuals from Maracaibo, Venezuela
ArticleAbstract: Coronary artery disease is the main cause of death worldwide. Lipoprotein(a) [Lp(a)], is an independPalabras claves:Cardiovascular Risk, Lifestyle, lipoprotein(a), Physical activityAutores:Acosta L., Añez-Ramos R., Aparicio D., Arráiz N., Cano R.A., Cano-Ponce C., Colmenares C., Faria J., Finol F., Mengual-Moreno E., Peñaranda L., Pineda C., Rodriguez D., Rojas E.R., Rojas-Quintero J., Sanchez W., Sorell L.T., Toledo A.C., Urribarí J., Valmore Bermúdez, Velasco M.Fuentes:scopusEthnic origin and cardiovascular disease
Conference ObjectAbstract: Environment and genetic interaction during human evolution has pbkp_redisposed chronic-degenerativePalabras claves:Cardiovascular disease, ethnicity, RISK FACTORS, Thrifty genotype, Thrifty phenotypeAutores:Acosta L., Almarza J., Aparicio D., Bustamante M., Carrillo M., Colmenares C., Finol F., Leal E.M., Linares S., Peña G., Rojas-Quintero J., Urdaneta A., Valmore BermúdezFuentes:scopusPPAR-γ agonists and their role in type 2 diabetes mellitus management
ReviewAbstract: Type 2 diabetes mellitus and obesity are the most frequent endocrine-metabolic diseases in the worldPalabras claves:diabetes mellitus, Insulin Resistance, PPARI, ThiazolidenedionesAutores:Arráiz N., Finol F., Parra M.G., Parra N., Peñaranda L., Pérez A., Rojas-Quintero J., Valmore Bermúdez, Velasco M., Vílchez D.Fuentes:scopusInfection, inflammation and atherosclerotic vascular disease
ReviewAbstract: Cardiovascular disease (CVD) is the leading cause of death in developed countries. The causes of thiPalabras claves:atherosclerosis, Cardiovascular disease, Chlamydia, infection, inflammation, risk factorAutores:Aparicio D., Canelón R., Finol F., Luis Xavier Enríquez Acosta, Martínez Y., Rojas E.R., Valmore Bermúdez, Velasco M.Fuentes:scopusInsulin resistance and hyperinsulinemia as risk factors for cardiovascular disease
Conference ObjectAbstract: Insulin resistance is defined as a metabolic state in which insulin peripheral effects are diminishePalabras claves:Cardiovascular disease, Hiperinsulinemia, Insulin, Insulin ResistanceAutores:Acosta L., Aparicio D., Arráiz N., Canelón R., Cano R.A., Deisiree S., Finol F., Leal E.M., Linares S., Luti Y., Rojas E.R., Rojas-Quintero J., Valmore BermúdezFuentes:scopusPharmacologic management of isolated low high-density lipoprotein syndrome
ArticleAbstract: High-density lipoprotein (HDL) cholesterol is a heterogeneous group of lipoproteins exhibiting a varPalabras claves:atherosclerosis, cholesterol, Coronary artery disease, dyslipidemia, HDLc, Reverse cholesterol transportAutores:Acosta L., Amell A., Arráiz N., Bermúdez F.A., Cano R.A., Cano-Ponce C., Finol F., Hernández-Hernandez R., Hidalgo J., Kendall P., Manuel V., Pabón M.R., Reyna-Villasmil N., Valmore BermúdezFuentes:scopusPhysical activity and cardiovascular disease
ReviewAbstract: Coronary artery diseases (CAD) are main cause of morbidity and mortality in western world. MultiplePalabras claves:atherosclerosis, Coronary heart disease, Physical activity, RISK FACTORS, Sedentary life-styleAutores:Aparicio D., Cabrera M., Finol F., Leal E.M., Luis Xavier Enríquez Acosta, Luti Y., Rojas E.R., Toledo A., Valmore Bermúdez, Velasco M.Fuentes:scopusThe maracaibo city metabolic syndrome prevalence study: Design and scope
ArticleAbstract: The metabolic syndrome (MS) is a conglomerate of interrelated risk factors-including obesity, atheroPalabras claves:Blood pressure, Cardiovascular Risk Factors, cross-sectional studies, dyslipidemia, Metabolic syndromeAutores:Amell A., Arráiz N., Cabrera M., Cano J.R., Cano R.A., Cano-Ponce C., Finol F., González J., Luti Y., Marcano R.P., Mengual-Moreno E., Miranda J.L., Montes J., Reyna-Villasmil N., Rojas E.R., Sánchez D., Sanchez W., Valmore Bermúdez, Vega L., Velasco M.Fuentes:scopus